Kevin Waters, Executive Vice President and CFO of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 373 shares of common stock on September 9, 2026, as part of the company's sell-to-cover process for tax withholding obligations.

Key Highlights

  • Reporting Person: Kevin Waters, EVP and CFO of PROCEPT BioRobotics Corp
  • Shares Disposed: 373 shares of common stock sold on September 9, 2026
  • Sale Price: $20.953 per share
  • Purpose: Shares sold pursuant to the issuer's sell-to-cover process for tax withholding obligations tied to RSU vesting on September 5, 2026
  • Remaining Ownership: 180,355 shares of common stock held directly following the transaction

PROCEPT BioRobotics CFO Reports RSU Vesting-Related Share Disposal

According to the Form 4 filed with the SEC on September 10, 2026, Kevin Waters, who serves as Executive Vice President and Chief Financial Officer of PROCEPT BioRobotics Corp, disposed of 373 shares of the company's common stock on September 9, 2026, at a price of $20.953 per share. The filing notes that the shares were sold under transaction code "S," indicating an open-market or equivalent sale.

The filing's footnote specifies that the disposal was not a discretionary market sale initiated by Waters. Rather, the shares "were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026." This mechanism is commonly used by companies to satisfy an employee's tax liability at vesting by selling a portion of the vested shares on the employee's behalf.

Following the reported transaction, Waters directly held 180,355 shares of PROCEPT BioRobotics common stock, according to the filing. No derivative securities transactions were reported. The Form 4 was signed by Jonathan Stone as attorney-in-fact for Kevin Waters and filed on September 10, 2026.

What Was Disclosed

The filing discloses a disposition of 373 shares of PROCEPT BioRobotics common stock by CFO Kevin Waters at $20.953 per share on September 9, 2026, executed through the company's sell-to-cover tax withholding process upon RSU vesting, leaving Waters with 180,355 directly held shares.